Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Cepheid Gets FDA Approval for Trichomonas Test in Men

Cepheid Gets FDA Approval for Trichomonas Test in Men

Sep 07, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Cepheid said yesterday that the US Food and Drug Administration has expanded its approval for Xpert TV, the company's urine-based test for trichomonas, to include its use in symptomatic and asymptomatic men.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Jun
04
Featured Webinar

COVID-19 Testing, Treatment and Future Outlook

Sponsored by
Ovation

This webinar will discuss the current status of COVID-19 testing, treatment and other aspects of the current pandemic as they relate to getting this outbreak under control.  

Jul
15
Featured Webinar

Diagnostic Challenges in Cancer Immunotherapy: An Expert Panel Discussion

Sponsored by
LGC SeraCare Life Sciences

Cancer immunotherapy is an exciting new advance for the successful treatment of many forms of metastatic cancer.

What's Popular?

In Molecular Diagnostics

  1. FDA Releases Reference Panel for Coronavirus Test Developers

  2. Congress Introduces Bipartisan Bills to Improve Access to SARS-CoV-2 Testing

  3. AMP SARS-CoV-2 Molecular Dx Survey Shows Supply Chain Issues Hampered Ramp Up of Testing

  4. LetsGetChecked At-Home Molecular SARS-CoV-2 Test Nabs FDA Emergency Use Authorization

  5. AACC Sends Testing Recommendations to Senate For SARS-CoV-2 Relief Bill

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.